Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'BABU YS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 27 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Sidwell, RW; Smee, DF; Huffman, JH; Barnard, DL; Morrey, JD; Bailey, KW; Feng, WC; Babu, YS; Bush, K
      Influence of virus strain, challenge dose, and time of therapy initiation on the in vivo influenza inhibitory effects of RWJ-270201

      ANTIVIRAL RESEARCH
    2. Bantia, S; Parker, CD; Ananth, SL; Horn, LL; Andries, K; Chand, P; Kotian, PL; Dehghani, A; El-Kattan, Y; Lin, T; Hutchison, TL; Montgomery, JA; Kellog, DL; Babu, YS
      Comparison of the anti-influenza virus activity of RWJ-270201 with those of oseltamivir and zanamivir

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    3. Sidwell, RW; Smee, DF; Huffman, JH; Barnard, DL; Bailey, KW; Morrey, JD; Babu, YS
      In vivo influenza virus-inhibitory effects of the cyclopentane neuraminidase inhibitor RWJ-270201

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    4. Chand, P; Kotian, PL; Dehghani, A; El-Kattan, Y; Lin, TH; Hutchison, TL; Babu, YS; Bantia, S; Elliott, AJ; Montgomery, JA
      Systematic structure-based design and stereoselective synthesis of novel multisubstituted cyclopentane derivatives with potent antiinfluenza activity

      JOURNAL OF MEDICINAL CHEMISTRY
    5. Babu, YS; Chand, P; Bantia, S; Kotian, P; Dehghani, A; El-Kattan, Y; Lin, TH; Hutchison, TL; Elliott, AJ; Parker, CD; Ananth, SL; Horn, LL; Laver, GW; Montgomery, JA
      BCX-1812 (RWJ-270201): Discovery of a novel, highly potent, orally active,and selective influenza neuraminidase inhibitor through structure-based drug design

      JOURNAL OF MEDICINAL CHEMISTRY
    6. Szalai, AJ; Digerness, SB; Agrawal, A; Kearney, JF; Bucy, RP; Niwas, S; Kilpatrick, JM; Babu, YS; Volanakis, JE
      The Arthus reaction in rodents: Species-specific requirement of complement

      JOURNAL OF IMMUNOLOGY
    7. Narayana, SVL; Babu, YS; Valanakis, JE
      Inhibition of complement serine proteases as a therapeutic strategy

      THERAPEUTIC INTERVENTIONS IN THE COMPLEMENT SYSTEM
    8. Atigadda, VR; Brouillette, WJ; Duarte, F; Babu, YS; Bantia, S; Chand, P; Chu, NM; Montgomery, JA; Walsh, DA; Sudbeck, E; Finley, J; Air, GM; Luo, M; Laver, GW
      Hydrophobic benzoic acids as inhibitors of influenza neuraminidase

      BIOORGANIC & MEDICINAL CHEMISTRY
    9. Brouillette, WJ; Atigadda, VR; Duarte, F; Luo, D; Air, GM; Babu, YS; Bantia, S
      Design of benzoic acid inhibitors of influenza neuraminidase containing a cyclic substitution for the N-acetyl grouping (vol 9, pg 1901, 1999)

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    10. Brouillette, WJ; Atigadda, VR; Luo, M; Air, GM; Babu, YS; Bantia, S
      Design of benzoic acid inhibitors of influenza neuraminidase containing a cyclic substitution for the N-acetyl grouping

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    11. Atigadda, VR; Brouillette, WJ; Duarte, F; Ali, SM; Babu, YS; Bantia, S; Chand, P; Chu, N; Montgomery, JA; Walsh, DA; Sudbeck, EA; Finley, J; Luo, M; Air, GM; Laver, GW
      Potent inhibition of influenza sialidase by a benzoic acid containing a 2-pyrrolidinone substituent

      JOURNAL OF MEDICINAL CHEMISTRY
    12. COLE LB; KILPATRICK JM; CHU NM; BABU YS
      STRUCTURE OF 3,4-DICHLOROISOCOUMARIN-INHIBITED FACTOR-D

      Acta crystallographica. Section D, Biological crystallography
    13. KILPATRICK JM; RUSTAGI PK; NIWAS S; SZALAI A; BABU YS
      USE OF NOVEL BROADLY REACTIVE SERINE-PROTEASE INHIBITORS AS SIMULTANEOUS ANTICOAGULANT AND ANTIINFLAMMATORY AGENTS

      The FASEB journal
    14. BANTIA S; GHATE AA; ANANTH SL; BABU YS; AIR GM; WALSH GM
      GENERATION AND CHARACTERIZATION OF A MUTANT OF INFLUENZA-A VIRUS SELECTED WITH THE NEURAMINIDASE INHIBITOR BCX-140

      Antimicrobial agents and chemotherapy
    15. JING H; BABU YS; MOORE D; KILPATRICK JM; LIU XY; VOLANAKIS JE; NARAYANA SVL
      STRUCTURES OF NATIVE AND COMPLEXED COMPLEMENT FACTOR-D - IMPLICATIONSOF THE ATYPICAL HIS57 CONFORMATION AND SELF-INHIBITORY LOOP IN THE REGULATION OF SPECIFIC SERINE-PROTEASE ACTIVITY

      Journal of Molecular Biology
    16. FARRELL DM; WEI CC; BRADLEY WE; HAGEMAN G; BABU YS; CHEN YF; OPARIL S
      INHIBITION OF ANGIOTENSIN-II FORMATION IN THE DOG HEART IN-VIVO BY A NOVEL SERINE-PROTEASE INHIBITOR BCX-1470

      Circulation
    17. COLE LB; CHU NM; KILPATRICK JM; VOLANAKIS JE; NARAYANA SVL; BABU YS
      STRUCTURE OF DIISOPROPYL FLUOROPHOSPHATE-INHIBITED FACTOR-D

      Acta crystallographica. Section D, Biological crystallography
    18. SUDBECK EA; JEDRZEJAS MJ; SINGH S; BROUILLETTE WJ; AIR GM; LAVER WG; BABU YS; BANTIA S; CHAND P; CHU N; MONTGOMERY JA; WALSH DA; LUO M
      GUANIDINOBENZOIC ACID INHIBITORS OF INFLUENZA-VIRUS NEURAMINIDASE

      Journal of Molecular Biology
    19. CHAND P; BABU YS; BANTIA S; CHU NM; COLE LB; KOTIAN PL; LAVER WG; MONTGOMERY JA; PATHAK VP; PETTY SL; SHROUT DP; WALSH DA; WALSH GW
      DESIGN AND SYNTHESIS OF BENZOIC-ACID DERIVATIVES AS INFLUENZA NEURAMINIDASE INHIBITORS USING STRUCTURE-BASED DRUG DESIGN

      Journal of medicinal chemistry
    20. RUSTAGI PK; KILPATRICK JM; NIWAS S; BABU YS
      INHIBITION OF COAGULATION AND COMPLEMENT BY NOVEL BROADLY-REACTIVE SERINE PROTEINASE-INHIBITORS

      Blood
    21. BABU YS; EALICK SE; BUGG CE; ERION MD; GUIDA WC; MONTGOMERY JA; SECRIST JA
      STRUCTURE-BASED DESIGN OF INHIBITORS OF PURINE NUCLEOSIDE PHOSPHORYLASE

      Acta crystallographica. Section D, Biological crystallography
    22. CARSON M; YANG Z; BABU YS; MONTGOMERY JA
      CALCULATION OF RELATIVE BINDING AFFINITIES OF PURINE NUCLEOSIDE PHOSPHORYLASE INHIBITORS

      Acta crystallographica. Section D, Biological crystallography
    23. GUIDA WC; ELLIOTT RD; THOMAS HJ; SECRIST JA; BABU YS; BUGG CE; ERION MD; EALICK SE; MONTGOMERY JA
      STRUCTURE-BASED DESIGN OF INHIBITORS OF PURINE NUCLEOSIDE PHOSPHORYLASE .4. A STUDY OF PHOSPHATE MIMICS

      Journal of medicinal chemistry
    24. ERION MD; NIWAS S; ROSE JD; ANANTHAN S; ALLEN M; SECRIST JA; BABU YS; BUGG CE; GUIDA WC; EALICK SE; MONTGOMERY JA
      STRUCTURE-BASED DESIGN OF INHIBITORS OF PURINE NUCLEOSIDE PHOSPHORYLASE .3. 9-ARYLMETHYL DERIVATIVES OF 9-DEAZAGUANINE SUBSTITUTED ON THE METHYLENE GROUP (VOL 36, PG 3773, 1993)

      Journal of medicinal chemistry
    25. BOSSARTWHITAKER P; CARSON M; BABU YS; SMITH CD; LAVER WG; AIR GM
      3-DIMENSIONAL STRUCTURE OF INFLUENZA-A N9 NEURAMINIDASE AND ITS COMPLEX WITH THE INHIBITOR 2-DEOXY 2,3-DEHYDRO-N-ACETYL NEURAMINIC ACID

      Journal of Molecular Biology
    26. ERION MD; NIWAS S; ROSE JD; ANANTHAN S; ALLEN M; SECRIST JA; BABU YS; BUGG CE; GUIDA WC; EALICK SE; MONTGOMERY JA
      STRUCTURE-BASED DESIGN OF INHIBITORS OF PURINE NUCLEOSIDE PHOSPHORYLASE .3. 9-ARYLMETHYL DERIVATIVES OF 9-DEAZAGUANINE SUBSTITUTED ON THE METHYLENE GROUP

      Journal of medicinal chemistry
    27. SECRIST JA; NIWAS S; ROSE JD; BABU YS; BUGG CE; ERION MD; GUIDA WC; EALICK SE; MONTGOMERY JA
      STRUCTURE-BASED DESIGN OF INHIBITORS OF PURINE NUCLEOSIDE PHOSPHORYLASE .2. 9-ALICYCLIC AND 9-HETEROALICYCLIC DERIVATIVES OF 9-DEAZAGUANINE

      Journal of medicinal chemistry


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 22/10/20 alle ore 15:14:05